Læknablaðið - 01.10.1977, Page 29

HaLCiDeRm
in dermatology
• *
'•m
E

topical halcinonide 0.1%
/
>v-*
M
Z-''
'
-anew
corticosteroid
-aunique
bi-phasic base
giving controlled
potency for
prolonged activity
V
®> advanced aPProach ‘° <*<n treatm ent
• immediate penetration
• sustained activity
• excellent results in eczema
• significantly better
than betamethasone
17 valerate in the treatment
of psoriasis.
SQUIBB
Further information on request: E. R. Squibb and Scns Limiteo -e:a -:.=e T.% ckenham. TW1 3QT.